A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
ConditionPrimary Open Angle Glaucoma
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age22+
SponsorAmydis Inc.
About this trial
The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).
Eligibility criteria
Qualifiers
Diagnosis of primary open angle glaucoma in both eyes
Able to fixate
Glaucomatous optic nerve damage in both eyes, as determined by an investigator as part of an eye exam
Disqualifiers
Participants unable to read or write
Ocular media is not sufficiently clear to obtain acceptable quality images
Participants with presence of any ocular pathology other than glaucoma in the study eye (cataracts are acceptable)
Trial design
Treatments tested in this trial
- AMDX-2011P
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov